Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

616 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bempedoic acid safety analysis: Pooled data from four phase 3 clinical trials.
Bays HE, Banach M, Catapano AL, Duell PB, Gotto AM Jr, Laufs U, Leiter LA, Mancini GBJ, Ray KK, Bloedon LT, Sasiela WJ, Ye Z, Ballantyne CM. Bays HE, et al. Among authors: leiter la. J Clin Lipidol. 2020 Sep-Oct;14(5):649-659.e6. doi: 10.1016/j.jacl.2020.08.009. Epub 2020 Sep 2. J Clin Lipidol. 2020. PMID: 32980290 Free article.
Statin therapy and the management of acute coronary syndromes.
Langer A, Constance C, Fodor JG, Frohlich JJ, Grégoire J, Lau DC, Leiter LA, Mancini GB, Marr D, McPherson R, O'Neill BJ, Rabkin SW. Langer A, et al. Among authors: leiter la. Can J Cardiol. 2003 Jul;19(8):921-7. Can J Cardiol. 2003. PMID: 12876613 Review.
Clinical use of ezetimibe.
Cheng AY, Leiter LA. Cheng AY, et al. Among authors: leiter la. Can J Clin Pharmacol. 2003 Winter;10 Suppl A:21A-5A. Can J Clin Pharmacol. 2003. PMID: 14571302 Review.
Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
Conard SE, Bays HE, Leiter LA, Bird SR, Rubino J, Lowe RS, Tomassini JE, Tershakovec AM. Conard SE, et al. Among authors: leiter la. Am J Cardiol. 2008 Dec 1;102(11):1489-94. doi: 10.1016/j.amjcard.2008.09.075. Epub 2008 Oct 23. Am J Cardiol. 2008. PMID: 19026302 Clinical Trial.
Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome.
Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J; dal-OUTCOMES Committees and Investigators. Schwartz GG, et al. Among authors: leiter la. Am Heart J. 2009 Dec;158(6):896-901.e3. doi: 10.1016/j.ahj.2009.09.017. Am Heart J. 2009. PMID: 19958854 Clinical Trial.
616 results